Cladribine Combined with Idarubicin and Ara-C (CLIA) As a Frontline and Salvage Treatment for Young Patients (≤65 yrs) with Acute Myeloid Leukemia

被引：10
|
作者：
Jain, Preetesh [1 ]
Kantarjian, Hagop M. [1 ]
Ravandi, Farhad [1 ]
Jabbour, Elias [1 ]
Daver, Naval [1 ]
Pemmaraju, Naveen [1 ]
DiNardo, Courtney D. [1 ]
Alvarado, Yesid [1 ]
Jain, Nitin [1 ]
Borthakur, Gautam [1 ]
Verstovsek, Srdan [1 ]
Ferrajoli, Alessandra [1 ]
Ohanian, Maro [1 ]
Konopleva, Marina [1 ]
Naqvi, Kiran [1 ]
Fitch, Tina [1 ]
Garcia-Manero, Guillermo [1 ]
Cortes, Jorge E. [1 ]
Estrov, Zeev [1 ]
Kadia, Tapan M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.1639.1639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1639
引用
收藏
页数：6
相关论文
共 50 条
  • [21] CLADRIBINE(2-CDA) AND CYTARABINE(ARA-C) IS AN EFFECTIVE SALVAGE REGIMEN IN REFRACTORY/RELAPSED ACUTE MYELOID LEUKAEMIA IN CHILDREN
    Chinnaswamy, Girish
    Prasad, Maya
    Dwivedi, Pankaj
    Patil, Vijay
    Arora, Brijesh
    Banavali, Shripad
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1040 - 1040
  • [22] Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia
    Montillo, Marco
    Ricci, Francesca
    Tedeschi, Alessandra
    Cafro, Anna Maria
    Nosari, Anna Maria
    Nichelatti, Michele
    Marbello, Laura
    Morra, Enrica
    LEUKEMIA RESEARCH, 2009, 33 (08) : 1072 - 1078
  • [23] Interim analysis of cytarabine (ara-C) and cladribine (2-CDA) combination therapy in acute myeloid leukemia (AML).
    Radomski, KM
    Gandhi, V
    Srivastava, DK
    Razzouk, BI
    Behm, FG
    Plunkett, W
    Pui, CH
    Rubnitz, JE
    Ribeiro, RC
    BLOOD, 2000, 96 (11) : 327A - 327A
  • [24] FLAG salvage therapy combined with idarubicin in relapsed/refractory acute myeloid leukemia
    Westhus, Jonas
    Noppeney, Richard
    Duehrsen, Ulrich
    Hanoun, Maher
    LEUKEMIA & LYMPHOMA, 2019, 60 (04) : 1014 - 1022
  • [25] Cladribine, cytarabine and idarubicin (CLA-Ida) salvage chemotherapy in relapsed acute myeloid leukemia (AML)
    Fridle, Chantal
    Medinger, Michael
    Wilk, Matthias C.
    Seipel, Katja
    Passweg, Jakob
    Manz, Markus G.
    Pabst, Thomas
    LEUKEMIA & LYMPHOMA, 2017, 58 (05) : 1068 - 1075
  • [26] Combination therapy with aclarubicine, etoposide and Ara-c (AVA) in the treatment of acute myeloid leukemia in the elderly
    Staib, P
    Lathan, B
    Steinmetz, HT
    Schwonzen, M
    KnoppelSchwark, S
    Wickramanayke, PD
    Tesch, H
    Diehl, V
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 852 - 852
  • [27] HIGH-DOSE ARA-C TREATMENT OF PATIENTS WITH ACUTE-LEUKEMIA
    HENKE, M
    HECHT, T
    EMMERICH, BS
    BROSS, KJ
    LOHR, GW
    BLUT, 1987, 55 (04): : 313 - 313
  • [28] Phase I/II study of idarubicin (Ida), high-dose ara-C, and sorafenib (S) in patients (pts) younger than 65 years with acute myeloid leukemia (AML)
    Kashani, F. Ravandi
    Cortes, J.
    Faderl, S.
    Jones, D.
    Byrd, A.
    Brandt, M.
    Garcia-Manero, G.
    Levis, M.
    Andreeff, M.
    Kantarjian, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [29] Idarubicin and intermediate dose ARA-C followed by consolidation chemotherapy or bone marrow transplantation in relapsed or refractory acute myeloid leukemia
    DelaSerna, J
    Tomas, JF
    Solano, C
    DeParedes, MLG
    Campbell, J
    Grande, C
    DiazMediavilla, J
    LEUKEMIA & LYMPHOMA, 1997, 25 (3-4) : 365 - 372
  • [30] Phase II Study of Cladribine, Idarubicin, Cytarabine (CLIA) Plus Gilteritinib in Patients with FLT3 Mutated Acute Myeloid Leukemia (AML)
    Abuasab, Tareq
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Montalban-Bravo, Guillermo
    Alvarado, Yesid
    Yilmaz, Musa
    Pemmaraju, Naveen
    Chien, Kelly S.
    Mohamed, Shehab Fareed
    Daver, Naval
    Kornblau, Steven M.
    Burger, Jan A.
    Jain, Nitin
    Islam, Rubiul
    DiNardo, Courtney D.
    Borthakur, Gautam
    Ravandi, Farhad
    Kadia, Tapan M.
    BLOOD, 2021, 138
12345